NCT03975829 2026-02-13Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Active not recruiting163 enrolled
NCT02684058 2023-12-13Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsNovartisPhase 2 Completed151 enrolled 45 charts 1 FDA
NCT00003458 2022-03-07Antineoplaston Therapy in Treating Children With Brain TumorsBurzynski Research InstitutePhase 2 Completed34 enrolled 6 charts
NCT00003457 2017-08-22Antineoplaston Therapy in Treating Patients With Brain TumorsBurzynski Research InstitutePhase 2 Completed40 enrolled 6 charts